1,024 material Form 8-K filings that 799 companies we cover made with the SEC in August 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Victory Capital reported second-quarter 2025 revenue of $351.2 million, up 59.9% from a year earlier, after closing its Amundi US acquisition on April 1, 2025. GAAP net income fell 21% to $58.7 million and GAAP diluted EPS was $0.68 versus $1.12, as higher variable operating expenses and acquisition and restructuring costs pushed the GAAP operating margin down to 26.8%. The board raised the share repurchase authorization to $500 million and approved a $0.49 quarterly dividend.
Revenue was $351.2 million, up 59.9% from a year earlier and from $219.6 million in the first quarter of 2025.
GAAP diluted EPS was $0.68 versus $1.12 a year earlier; adjusted net income with tax benefit per diluted share was $1.57 versus $1.31.
GAAP operating margin was 26.8% versus 50.4%; acquisition-related costs were $25.8 million and restructuring and integration costs were $14.0 million.
The share repurchase authorization rose from $200.0 million to up to $500.0 million; the $0.49 dividend is payable September 25, 2025.
Concentra Group Holdings Parent reported second-quarter 2025 revenue of $550.8 million, up 15.2%, and raised its full-year 2025 revenue and Adjusted EBITDA guidance. Net income fell 12.9% to $46.2 million, and earnings per share fell to $0.35 from $0.50, which the company attributed to higher interest expense from its IPO recapitalization.
Q2 2025 revenue was $550.8 million, up 15.2% from $477.9 million; Adjusted EBITDA was $115.0 million, up 13.2% from $101.6 million.
Q2 2025 net income was $46.2 million versus $53.1 million a year earlier; EPS was $0.35 versus $0.50.
2025 revenue guidance was raised to $2.13 billion to $2.16 billion, and Adjusted EBITDA guidance is $420 million to $430 million.
The board declared a cash dividend of $0.0625 per share, payable August 28, 2025, to holders of record on August 21, 2025.
Assured Guaranty reported second quarter 2025 GAAP net income of $103 million, or $2.08 per diluted share, up from $78 million, or $1.41, a year earlier. Adjusted operating income fell to $50 million, or $1.01 per share, from $80 million, or $1.44, and the company said the GAAP gain included a $71 million pre-tax foreign exchange gain that it excludes from adjusted results. The board also raised its share repurchase authorization by $300 million on August 6, 2025.
GAAP net income attributable to Assured Guaranty was $103 million, or $2.08 per diluted share, versus $78 million, or $1.41, in Q2 2024.
Adjusted operating income was $50 million, or $1.01 per share, versus $80 million, or $1.44, in Q2 2024.
Shareholders' equity per share was a record $117.10 as of June 30, 2025.
Capital returned in Q2 2025 was $150 million, including $131 million of share repurchases and $19 million of dividends; the board authorized an additional $300 million of repurchases on August 6, 2025.
Sezzle reported second-quarter 2025 results, with total revenue up 76.4% year over year to $98.7 million and operating income up 116.1% to $36.1 million. Net income fell 7.1% to $27.6 million and diluted earnings per share fell 4.9% to $0.78, mainly because the prior-year quarter included a $16.1 million income tax benefit. The company also said it will let its B Corporation certification expire, which it does not expect to have a material impact on the business.
Total revenue of $98.7 million, up 76.4%; gross merchandise volume reached $927.0 million, up 74.2%
Net income of $27.6 million versus $29.7 million a year earlier; diluted EPS of $0.78 versus $0.82, with a $5.1 million tax expense in 2Q25 compared with a $16.1 million benefit in 2Q24
FY2025 guidance includes Adjusted EBITDA of $170.0 million to $175.0 million and Adjusted Net Income of $120.0 million
B Corporation certification expires effective immediately after the company elected to forgo recertification; it remains a Public Benefit Corporation
Brighthouse Financial reported second-quarter 2025 net income available to shareholders of $60 million, or $1.02 per diluted share, up from $9 million, or $0.12 per share, a year earlier. Adjusted earnings, the measure management uses to evaluate performance, fell to $198 million, or $3.43 per diluted share, from $346 million, or $5.57 per share, in the second quarter of 2024.
Net income available to shareholders: $60 million ($1.02 per diluted share) vs. $9 million ($0.12) in Q2 2024
Adjusted earnings: $198 million ($3.43 per diluted share) vs. $346 million ($5.57) in Q2 2024
Annuity sales of $2.6 billion, including $1.9 billion of Shield Level Annuities; repurchased $43 million of common stock in the quarter
Estimated combined RBC ratio between 405% and 425%; holding company liquid assets of $0.9 billion as of June 30, 2025
Synaptics reported fourth-quarter fiscal 2025 revenue of $282.8 million, up from $247.4 million a year earlier, but a GAAP net loss of $4.7 million, compared with net income of $208.3 million a year earlier. The company also guided first-quarter fiscal 2026 revenue to $290 million plus or minus $10 million and authorized a new buyback of up to $150 million of common stock, which has no expiration date.
Q4 non-GAAP diluted EPS was $1.01, versus $0.64 a year earlier; Q4 GAAP loss was $0.12 per basic share.
Prior-year Q4 GAAP net income of $208.3 million included a $245.0 million income tax benefit.
Q1 fiscal 2026 guidance: revenue $290 million ± $10 million; GAAP loss per share ($0.54) ± $0.25.
Board authorized the buyback of up to $150 million on August 5, 2025; the company repurchased $128 million of stock in fiscal 2025.
Dropbox reported second-quarter 2025 results for the quarter ended June 30, 2025, with revenue of $625.7 million, down 1.4% from a year earlier, while GAAP diluted earnings per share rose to $0.45 from $0.34. The filing does not include forward guidance, which the company said it would provide on its earnings call and investor website.
Revenue was $625.7 million, down 1.4% year over year; paying users were 18.13 million, versus 18.22 million a year earlier.
GAAP operating margin was 26.9%, up from 20.0%; the company cited lower employee-related costs from a decrease in headcount.
Free cash flow was $258.5 million, up from $224.7 million; common stock repurchases were $410.0 million in the quarter.
The filing states no financial outlook; guidance was to be provided on the August 7, 2025 conference call and website.
Live Nation reported second-quarter 2025 revenue of $7.0 billion, up 16%, and adjusted operating income of $798 million, up 11%. Diluted earnings per share fell to $0.41 from $1.03 a year earlier, and net income attributable to common stockholders dropped to $243 million from $298 million. The company said it is positioned to grow operating income and AOI by double digits in 2025, and expects its additional 24% purchase of OCESA to close in August.
Revenue of $7.0 billion, up 16%; operating income of $487 million, up 4%
Diluted EPS of $0.41 versus $1.03 a year earlier; net income attributable to common stockholders of $243 million versus $298 million
Accretion, higher taxes and foreign exchange added $185 million to Q2 costs compared with last year
OCESA purchase would raise ownership to 75%, expected to close in August; Q3 accretion expected at $250 million
Onto Innovation reported fiscal second quarter 2025 revenue of $253.6 million, up 5% from a year earlier, while GAAP net income fell to $33.9 million, or $0.69 per share, from $52.9 million, or $1.07 per share. The company guided third-quarter revenue to $210 million to $225 million and announced a pending acquisition of Semilab product lines for approximately $545 million in cash and stock.
Q2 2025 revenue of $253.6 million, up 5% year-over-year; GAAP operating margin 12.7% vs. 20.2% a year earlier
Non-GAAP net income of $61.3 million, or $1.25 per share, vs. $65.4 million, or $1.32 per share, in Q2 2024
Q3 2025 outlook: revenue of $210 million to $225 million and GAAP diluted EPS of $0.52 to $0.72
Semilab acquisition for approximately $545 million in cash and stock, expected to add more than $130 million in annual revenue
Saul Centers reported second-quarter 2025 results with total revenue up to $70.8 million from $66.9 million a year earlier, while net income fell to $14.2 million from $19.5 million. Management attributed the profit decline mainly to the initial operations of Twinbrook Quarter Phase I, which reduced net income by $5.4 million, including a $3.5 million reduction in capitalized interest. For shareholders, net income available to common stockholders dropped to $0.33 per share from $0.48, and funds from operations fell to $0.73 per share from $0.83.
Total revenue rose to $70.8 million for the quarter ended June 30, 2025, from $66.9 million a year earlier.
Net income available to common stockholders fell to $7.9 million, or $0.33 per share, from $11.6 million, or $0.48 per share.
Same property net operating income decreased 4.3% to $48.1 million, with lower lease termination fees cited as a key factor in the shopping center segment.
As of June 30, 2025, 94.0% of the commercial portfolio was leased, compared with 95.8% a year earlier.
For the quarter ended June 30, 2025, Microchip reported net sales of $1.0755 billion, up 10.8% sequentially, down 13.4% from a year earlier, and above the $1.0575 billion midpoint of its May 29, 2025 guidance. The company posted a GAAP net loss attributable to common stockholders of $46.4 million, or $0.09 per diluted share, compared with GAAP net income of $129.3 million a year earlier, and guided September quarter net sales to $1.130 billion plus or minus $20.0 million.
Net sales were $1.0755 billion, up 10.8% sequentially and down 13.4% from $1.241 billion in the year-earlier quarter.
GAAP net loss attributable to common stockholders was $46.4 million, or $0.09 per diluted share; non-GAAP net income was $154.7 million, or $0.27 per diluted share.
Inventory dollars fell $124.4 million during the quarter.
Board declared a quarterly common dividend of 45.5 cents per share, payable September 5, 2025 to holders of record on August 22, 2025.
Kratos reported second quarter 2025 revenue of $351.5 million, up 17.1 percent from $300.1 million a year earlier, while GAAP net income fell to $2.9 million, or $0.02 per share, from $7.9 million, or $0.05. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance and gave initial third-quarter guidance, but the second-quarter bookings-to-revenue ratio was 0.7 to 1.
Q2 2025 revenue was $351.5 million, up from $300.1 million, with organic growth of 15.2 percent.
GAAP net income was $2.9 million, or $0.02 per share, versus $7.9 million, or $0.05 per share, in Q2 2024; Adjusted EPS was $0.11 versus $0.14.
Full-year 2025 revenue guidance is $1.29 billion to $1.31 billion and Adjusted EBITDA guidance is $114 million to $120 million, both increased.
KUS segment reported an operating loss of $0.3 million in Q2 2025, compared with operating income of $3.6 million a year earlier.
Wynn Resorts reported second-quarter 2025 operating revenues of $1.74 billion, up $4.9 million from a year earlier, but net income attributable to the company fell to $66.2 million from $111.9 million. The company also declared a $0.25 per share cash dividend, payable August 29, 2025 to holders of record on August 18, 2025.
Diluted net income per share was $0.64, down from $0.91 in the second quarter of 2024.
Adjusted net income per diluted share was $1.09, compared with $1.12 a year earlier.
Adjusted Property EBITDAR was $552.4 million, down from $571.7 million, with Wynn Palace down $27.3 million.
Quarterly cash dividend of $0.25 per share; the company repurchased $158.1 million of stock during the quarter.
Rocket Lab reported second-quarter 2025 revenue of $144.5 million, up from $106.3 million a year earlier, and GAAP gross profit rose to $46.4 million from $27.2 million. Net loss widened to $66.4 million, or $0.13 per share, from $41.6 million, or $0.08 per share, a year earlier. The company also guided third-quarter revenue to $145 million to $155 million and an adjusted EBITDA loss of $21 million to $23 million.
Q2 2025 revenue was $144.5 million, up 36% from $106.3 million in Q2 2024.
GAAP net loss was $66.4 million ($0.13 per share), compared with a net loss of $41.6 million ($0.08 per share) a year earlier.
Non-GAAP gross margin was 36.9%, up from 30.7% in the prior-year quarter.
Q3 2025 guidance: revenue of $145 million to $155 million and an adjusted EBITDA loss of $21 million to $23 million.
Metallus reported second-quarter 2025 net sales of $304.6 million, up 3% from $294.7 million a year earlier, with GAAP net income of $3.7 million, or $0.09 per diluted share, versus $4.6 million, or $0.10, a year earlier. The company said third-quarter adjusted EBITDA is expected to be modestly lower than the second quarter, citing labor negotiation costs, higher electricity costs and planned shutdown maintenance.
Net sales $304.6 million, up 9% from $280.5 million in Q1 2025 and up 3% from Q2 2024
GAAP diluted EPS $0.09 vs. $0.10 in Q2 2024; adjusted diluted EPS $0.20 vs. $0.15; adjusted EBITDA $26.5 million vs. $19.9 million
Q3 2025 outlook: adjusted EBITDA modestly lower than Q2; annual shutdown maintenance costs about $15 million, with about $5 million in Q3
Labor negotiations with the United Steelworkers begin August 18, 2025; current contract expires September 29, 2025, with $3 million to $5 million of incremental cost expected in H2 2025
Goodyear reported second quarter 2025 net sales of $4.5 billion, down from $4.57 billion a year earlier, and net income of $254 million, or 87 cents per diluted share, up from $79 million. The increase reflects an estimated $385 million pre-tax gain on the Dunlop brand sale; excluding significant items, the company posted an adjusted net loss of $48 million versus adjusted net income of $48 million a year ago. The filing also discloses a correction to prior-period results tied to currency remeasurement in Turkey.
Net sales were $4.5 billion ($4,465 million) versus $4,570 million in Q2 2024.
Adjusted diluted EPS was a loss of $0.17, compared with earnings of $0.17 a year earlier.
Segment operating income was $159 million versus $334 million, including $195 million of Goodyear Forward benefits.
The Dunlop brand sale closed May 7, 2025 with $735 million in gross cash proceeds; the Chemical business sale is expected to close in late 2025.
PTC Therapeutics reported second-quarter 2025 total revenue of $178.9 million, down from $186.7 million a year earlier, while its net loss narrowed to $64.8 million from $99.2 million. The company also reaffirmed no prior guidance in this filing but gave full-year 2025 revenue guidance of $650 million to $800 million, and said Sephience received FDA approval on July 28, 2025.
Q2 2025 total revenue $178.9 million vs. $186.7 million in Q2 2024; net product revenue $118.3 million vs. $133.2 million
Q2 2025 net loss $64.8 million, or $0.83 per share, vs. net loss of $99.2 million, or $1.29 per share, in Q2 2024
Full-year 2025 revenue guidance of $650 million to $800 million
Agreed to buy the Sephience sales obligation owed to former Censa shareholders for a $225 million upfront payment; cash and marketable securities were $1,989.2 million at June 30, 2025
Astrana Health reported second-quarter 2025 results on August 7, 2025. Total revenue rose 35% to $654.8 million, but net income attributable to the company fell to $9.4 million, or $0.19 per diluted share, from $19.2 million, or $0.40, a year earlier. The company reiterated full-year 2025 guidance, which includes the Prospect Health acquisition that closed July 1, 2025.
Q2 total revenue of $654.8 million, up 35% from $486.3 million; diluted EPS of $0.19 versus $0.40 a year earlier
Q2 adjusted EBITDA of $48.1 million versus $47.9 million; adjusted EBITDA margin of 7% versus 10%
Full-year 2025 guidance reiterated: total revenue of $3.1 billion to $3.3 billion and adjusted EBITDA of $215 million to $225 million
Prospect Health acquisition closed July 1, 2025, with purchase price reduced to $707.9 million from $745.0 million
ICU Medical reported second quarter 2025 revenue of $548.9 million, down from $596.5 million a year earlier, and GAAP net income of $35.3 million, or $1.43 per diluted share, which included a $41.8 million gain on sale of a business. The company also narrowed its 2025 adjusted EBITDA guidance to $380 million to $390 million from $380 million to $405 million, and adjusted diluted EPS guidance to $6.85 to $7.15 from $6.55 to $7.25, so shareholders face lower revenue and a lower top end for adjusted EBITDA guidance despite higher reported profit.
Q2 2025 revenue was $548.9 million versus $596.5 million in Q2 2024; Vital Care revenue fell to $108.0 million from $171.0 million.
GAAP net income was $35.3 million, or $1.43 per diluted share, versus a net loss of $21.4 million, or $0.88 per share, a year earlier.
Adjusted diluted EPS was $2.10 versus $1.56; adjusted EBITDA was $100.3 million versus $91.3 million.
Full-year 2025 adjusted EBITDA guidance high end lowered to $390 million from $405 million; the low end stayed at $380 million.
DiamondRock reported second-quarter 2025 net income attributable to common stockholders of $38.4 million, or $0.18 per diluted share, up 73.8% from a year earlier, while total revenues fell 1.2% to $305.7 million and Adjusted EBITDA fell 4.7% to $90.5 million. The company raised the midpoint of its 2025 Adjusted EBITDA and Adjusted FFO per share guidance and completed a $1.5 billion credit facility refinancing that it says leaves no debt maturities until 2028.
Net income attributable to common stockholders was $38.4 million, or $0.18 per diluted share, versus $22.1 million in the second quarter of 2024.
Total revenues were $305.7 million, down 1.2% from $309.3 million; Adjusted EBITDA was $90.5 million, down 4.7%.
2025 Adjusted EBITDA guidance is $275 million to $295 million, with the midpoint raised by $2.5 million; Adjusted FFO per share guidance is $0.96 to $1.06, with the midpoint raised by $0.01.
On July 22, 2025, the company completed a $1.5 billion refinancing of its senior unsecured credit facility.
BioLife Solutions reported unaudited second-quarter 2025 revenue of $25.4 million, up 29% from a year earlier, and raised its full-year 2025 revenue guidance to $100.0 million to $103.0 million. The GAAP net loss widened to $15.8 million, which includes a non-cash $15.5 million in-process R&D expense tied to the April 2025 PanTHERA acquisition.
Q2 2025 total revenue was $25.4 million, up from $19.7 million in Q2 2024.
GAAP net loss from continuing operations was $15.8 million, versus $5.6 million a year earlier, including a $15.5 million non-cash IPR&D expense.
Full-year 2025 revenue guidance was raised to $100.0 million to $103.0 million from $95.5 million to $99.0 million.
Adjusted EBITDA was $6.1 million, or 24% of revenue, compared with $3.9 million, or 20% of revenue, in Q2 2024.
Fox Factory reported fiscal second-quarter 2025 net sales of $374.9 million, up 7.6% from a year earlier, while net income fell to $2.7 million from $5.4 million. Adjusted earnings per diluted share rose to $0.40 from $0.38, and the company raised its expected full-year tariff expense to upwards of $50 million from about $38 million.
Q2 net sales $374.9 million vs. $348.5 million a year earlier; diluted EPS $0.07 vs. $0.13; adjusted diluted EPS $0.40 vs. $0.38
Six months ended July 4, 2025: net loss of $257.0 million, driven by a $262.1 million goodwill impairment
Full-year 2025 outlook: net sales $1.45 billion to $1.51 billion; adjusted EPS $1.60 to $2.00
Third-quarter 2025 outlook: net sales $370 million to $390 million; adjusted EPS $0.45 to $0.65
Hawaiian Electric Industries reported second-quarter 2025 net income for common stock of $26 million, or $0.15 per diluted share, compared with a net loss of $1,295 million in the same quarter of 2024, which included a $1,712 million wildfire-related charge at the utility. Excluding Maui wildfire costs and Pacific Current strategic review expenses, core income was $35 million, or $0.20 per share, down from $0.26 per share a year earlier, and total revenues fell to $746 million from $795 million.
Q2 2025 net income for common stock $26 million, or $0.15 per diluted share, versus a net loss of $1,295 million, or $11.74 per share, in Q2 2024
Core income from continuing operations $35 million, or $0.20 per share, versus $28 million, or $0.26 per share, in Q2 2024
Total revenues $746 million versus $795 million in Q2 2024
Hawaiian Electric board declared a $10 million cash dividend payable to HEI for Q2 2025
HASI reported second-quarter 2025 results on August 7, 2025, with GAAP diluted EPS of $0.74, up from $0.23 a year earlier, while adjusted EPS fell to $0.60 from $0.63. Total revenue declined to $85.7 million from $94.5 million, and the company reaffirmed its guidance for 8% to 10% compound annual adjusted EPS growth through 2027 and declared a $0.42 quarterly dividend. For shareholders, the GAAP gain reflected higher equity method income, while adjusted EPS and revenue moved lower.
GAAP diluted EPS was $0.74 in Q2 2025 versus $0.23 in Q2 2024; adjusted EPS was $0.60 versus $0.63, which the company attributed to higher shares outstanding.
Adjusted recurring net investment income was $85 million in Q2 2025, up 25% from Q2 2024.
Total revenue was $85.7 million versus $94.5 million a year earlier; gain on sale of assets was $7.8 million versus $25.8 million.
Adjusted EPS growth guidance of 8% to 10% compound annual rate through 2027 was reaffirmed; the $0.42 quarterly dividend is payable October 17, 2025, to holders of record as of October 3, 2025.
StepStone Group reported results for the quarter ended June 30, 2025, its first fiscal 2026 quarter. Total revenues rose 95% to $364.3 million, but the company posted a net loss of $12.0 million, or $0.49 per share, compared with net income of $48.0 million, or $0.20 per share, a year earlier. Adjusted net income fell 15% to $48.5 million, and the company declared a $0.28 quarterly dividend.
Total revenues were $364.3 million, up from $186.4 million a year earlier, with total performance fees of $153.1 million.
Net loss attributable to StepStone was $38.4 million, or $0.49 per share, versus net income of $13.3 million a year earlier. Equity-based compensation was $188.7 million, versus $19.2 million.
Adjusted net income was $48.5 million, or $0.40 per share, down from $57.2 million, or $0.48 per share. Fee-related earnings rose 13% to $81.2 million.
The board declared a $0.28 per share quarterly dividend, payable September 15, 2025, to holders of record on August 29, 2025.
Arrowhead Pharmaceuticals reported results for the fiscal 2025 third quarter ended June 30, 2025, with revenue of $27.8 million compared with none a year earlier. The net loss attributable to the company was $175.2 million, up from $170.8 million, while the diluted loss per share narrowed to $1.26 from $1.38. The filing also described a $130 million upfront payment from Sanofi tied to a Greater China deal for a majority-owned subsidiary, and a $100 million Sarepta milestone payment.
Revenue of $27.8 million in the quarter, versus $0 in the same period a year earlier
Net loss attributable to Arrowhead of $175.2 million, versus $170.8 million a year earlier; diluted loss per share of $1.26, versus $1.38
Research and development expenses of $162.4 million and general and administrative expenses of $30.9 million
Total cash resources of $900.4 million as of June 30, 2025, and a PDUFA action date of November 18, 2025 for plozasiran
Century Aluminum reported a second-quarter 2025 net loss attributable to stockholders of $4.6 million, compared with net income of $29.7 million in the first quarter, on net sales of $628.1 million, down $5.8 million sequentially. Adjusted EBITDA fell to $74.3 million, and the company expects third-quarter 2025 Adjusted EBITDA of $115-125 million, driven mainly by higher realized Midwest regional premium. Shareholders face a weaker reported quarter but a much stronger outlook.
Q2 2025 net loss attributable to Century stockholders of $4.6 million, or $(0.05) per diluted share, versus $29.7 million, or $0.29 per diluted share, in Q1 2025
Adjusted EPS was $0.30 versus $0.36 in Q1 2025; net exceptional items totaled $35.0 million, including a $14.5 million Iceland inventory adjustment, net of tax
Q3 2025 outlook: Adjusted EBITDA expected between $115 million and $125 million, versus $74.3 million in Q2 2025
Liquidity was $362.5 million at June 30, 2025, and the company announced plans to restart the last 50,000 metric tons of capacity at its Mt. Holly smelter
LegalZoom reported second-quarter 2025 revenue of $192.5 million, up 9% year over year, and a net loss of $0.3 million, compared with net income of $1.3 million a year earlier. The company raised its full-year 2025 revenue growth outlook to approximately 8% from 5%, while keeping its Adjusted EBITDA margin outlook at approximately 23%, so shareholders get faster top-line growth alongside a swing to a small loss.
Q2 revenue $192.5 million, up 9% year over year; subscription revenue $119.9 million, up 10%
Q2 net loss $0.3 million versus net income $1.3 million in Q2 2024; Adjusted EBITDA $39.0 million versus $28.9 million
2025 revenue growth outlook raised to approximately 8% from 5%; Adjusted EBITDA margin outlook maintained at approximately 23%
Q3 2025 outlook: revenue of $182 million to $184 million and Adjusted EBITDA of $44 million to $46 million
Expedia Group reported second quarter 2025 revenue of $3,786 million, up 6% from a year earlier, and gross bookings of $30,409 million, up 5%. GAAP diluted earnings per share fell 11% to $2.48, while adjusted EPS rose 21% to $4.24, and the company raised its full-year 2025 guidance. The company also declared a quarterly dividend of $0.40 per share and repurchased $627 million of shares in the quarter.
Q2 2025 revenue $3,786 million, up 6%; gross bookings $30,409 million, up 5%
GAAP diluted EPS $2.48, down 11%; adjusted EPS $4.24, up 21%
Full-year 2025 gross bookings guidance raised to 3-5% from 2-4%; revenue guidance raised to 3-5% from 2-4%
Quarterly dividend of $0.40 per share payable September 18, 2025 to holders of record on August 28, 2025
Sempra reported second-quarter 2025 GAAP earnings of $461 million, or $0.71 per diluted share, down from $713 million, or $1.12, a year earlier. Adjusted EPS was $0.89, matching the prior-year quarter, and adjusted earnings rose to $583 million from $567 million. The company updated its 2025 GAAP EPS guidance to $4.05 to $4.45 and affirmed its adjusted 2025 and 2026 EPS guidance ranges.
Q2 2025 GAAP earnings were $461 million ($0.71 per diluted share), versus $713 million ($1.12) in Q2 2024.
Q2 2025 adjusted EPS was $0.89, unchanged from Q2 2024; adjusted earnings were $583 million versus $567 million.
Q2 2025 total revenues were $3,000 million, compared with $3,011 million in Q2 2024.
2025 GAAP EPS guidance was updated to $4.05 to $4.45; 2025 adjusted EPS guidance of $4.30 to $4.70 and 2026 EPS guidance of $4.80 to $5.30 were affirmed.
APA reported second-quarter 2025 net income attributable to common stock of $603 million, or $1.67 per diluted share, up from $541 million, or $1.46, a year earlier, while total revenues fell to $2.18 billion from $2.54 billion. The company also accelerated its cost-reduction program to $350 million in run-rate savings by 2026 and reduced net debt by more than $850 million during the quarter, which matters to shareholders because it bears on both earnings quality and balance-sheet strength.
Net income attributable to common stock was $603 million, or $1.67 per diluted share, versus $541 million, or $1.46, in Q2 2024.
Total revenues were $2.18 billion, compared with $2.54 billion in the same quarter last year; adjusted earnings were $313 million, or $0.87 per diluted share.
Net debt fell to $4.4 billion at June 30, 2025, from $5.3 billion at March 31, 2025; APA returned $140 million to shareholders through dividends and buybacks.
The 2026 run-rate savings target of $350 million was pulled forward from year-end 2027, and the 2025 realized savings target rose to $200 million from $130 million.
Marcus & Millichap reported second quarter 2025 total revenue of $172.3 million, up 8.8% from a year earlier, but a net loss of $11.0 million, or $0.28 per diluted share, compared with a net loss of $5.5 million, or $0.14 per share, in the second quarter of 2024. The loss was widened by a $7.3 million income tax provision, primarily related to a change in tax methodology, and the company said the quarterly results are preliminary because its Form 10-Q has not yet been filed.
Total revenue was $172.3 million versus $158.4 million; brokerage commissions rose 4.4% to $141.4 million and financing fees rose 43.5% to $26.3 million.
Net loss was $11.0 million, or $0.28 per diluted share, versus a net loss of $5.5 million, or $0.14 per share, a year earlier.
The $7.3 million tax provision, primarily tied to a change in tax methodology, accounted for $0.19 of the diluted loss per share.
Middle Market and Larger Transaction Market brokerage revenue fell 6.6%; the Board declared a $0.25 per share dividend payable October 6, 2025.
ACI Worldwide reported second-quarter 2025 revenue of $401 million, up 7% from a year earlier, but net income fell to $12 million from $31 million and adjusted EBITDA fell 13% to $81 million. The company raised its full-year 2025 revenue and adjusted EBITDA guidance and repurchased 2.4 million shares for $119 million in the quarter, so shareholders see stronger full-year expectations alongside weaker quarterly profit.
Q2 2025 revenue was $401 million, up 7%; recurring revenue was $322 million, up 13%.
Q2 2025 diluted EPS was $0.12, versus $0.29 in Q2 2024; first-half net income of $71 million included a $22 million after-tax gain on the sale of the Mindgate stake.
Full-year 2025 revenue guidance was raised to $1.710 billion to $1.740 billion from $1.690 billion to $1.720 billion; adjusted EBITDA guidance was raised to $490 million to $505 million from $480 million to $495 million.
Q3 2025 guidance calls for revenue of $460 million to $470 million and adjusted EBITDA of $155 million to $165 million.
UGI reported a fiscal third-quarter GAAP net loss of $163 million, or $(0.76) per diluted share, compared with a loss of $48 million, or $(0.23), a year earlier. Adjusted diluted EPS was $(0.01) versus $0.06, and the company expects to finish fiscal 2025 at the top end of its $3.00 to $3.15 adjusted EPS guidance range.
Q3 revenue was $1,394 million versus $1,380 million a year earlier.
Year-to-date GAAP diluted EPS was $3.16 versus $2.52, and adjusted diluted EPS was $3.55 versus $3.22.
The company generated approximately $150 million from Global LPG asset sales in Hawaii, Italy and a small UK cylinder business.
Year-to-date free cash flow was $558 million, up 11% from the prior-year period.
MDU Resources reported second-quarter 2025 net income of $13.7 million, or $0.07 per diluted share, down from $60.4 million, or $0.30 per share, a year earlier. The prior-year figure included discontinued operations from the Everus spinoff. Operating revenues rose to $351.2 million from $344.5 million, and the company narrowed its 2025 earnings guidance to $0.88 to $0.95 per share.
Q2 2025 operating revenues were $351.2 million, up from $344.5 million; Q2 operating income was $30.4 million, down from $39.5 million
2025 EPS guidance narrowed to $0.88 to $0.95 per share; long-term EPS growth expectation of 6%-8% is unchanged
Electric segment net income fell to $10.4 million and natural gas distribution posted a seasonal loss of $7.4 million, citing higher operation and maintenance costs and warmer weather
Sabre reported second-quarter 2025 revenue of $687 million, down 1% from $695 million a year earlier, and a net loss attributable to common stockholders of $256 million, versus $70 million in the second quarter of 2024. Operating income rose to $89 million from $49 million, but the larger loss reflected higher tax provisions and an $85 million loss on debt extinguishment, and the company also updated its full-year 2025 outlook.
Revenue was $687 million, down 1% from $695 million in Q2 2024; net loss attributable to common stockholders was $256 million, versus $70 million.
Operating income was $89 million, up from $49 million, with operating margin of 13% versus 7%.
Closed the $1.1 billion sale of Hospitality Solutions in July 2025 and repaid more than $1 billion of debt.
Full-year 2025 pro forma Adjusted EBITDA scenarios range from about $530 million to $570 million, depending on industry bookings growth.
Warner Music Group reported results for the quarter ended June 30, 2025, with revenue up 9% to $1.689 billion, but a net loss of $16 million compared with net income of $141 million a year earlier. The company cited a $70 million loss from exchange rates on its Euro-denominated debt and a $68 million increase in restructuring and impairment charges, while Adjusted OIBDA rose 18% to $373 million. The board also declared a $0.19 per share quarterly dividend payable September 3, 2025.
Revenue rose 9% to $1.689 billion from $1.554 billion in the prior-year quarter.
Net loss was $16 million, or $(0.03) per share, versus net income of $141 million a year earlier.
Operating income fell 18% to $169 million, while Adjusted OIBDA rose 18% to $373 million.
Quarterly dividend of $0.19 per share is payable September 3, 2025, to holders of record as of August 20, 2025.
Collegium reported second-quarter 2025 product revenue of $188.0 million, up 29% from a year earlier, and raised its full-year 2025 product revenue guidance to $745 million to $760 million. GAAP net income fell to $12.0 million, or $0.34 per diluted share, from $19.6 million, or $0.52, a year earlier, as operating expenses rose. The company also authorized a $150 million share repurchase program running through December 31, 2026.
Q2 2025 product revenue of $188.0 million, up 29% year over year; Jornay PM net revenue of $32.6 million, with prescriptions up 23%
Full-year 2025 product revenue guidance raised to $745 million to $760 million, from $735 million to $750 million; adjusted EBITDA guidance raised to $440 million to $455 million
GAAP net income of $12.0 million ($0.34 diluted EPS) for Q2 2025, versus $19.6 million ($0.52) for Q2 2024
Board authorized a $150 million share repurchase program through December 31, 2026; cash and marketable securities were $222.2 million at June 30, 2025
Cogent Communications reported second-quarter 2025 service revenue of $246.2 million, down 0.3% from the first quarter and 5.5% from a year earlier, and a net loss of $57.8 million, or $(1.21) per share, compared with $(1.09) per share in the first quarter. The company also raised its quarterly dividend to $1.015 per share and increased its buyback program by $100.0 million, which matters to shareholders because it changes capital returns while headline revenue and loss figures moved in opposite directions.
Service revenue was $246.2 million for Q2 2025, versus $247.0 million for Q1 2025 and a 5.5% decline from Q2 2024.
Net loss was $57.8 million, or $(1.21) per share, versus $(1.09) per share in Q1 2025; EBITDA rose 10.8% sequentially to $48.5 million.
Net cash used in operating activities was $44.0 million in Q2 2025, compared with $36.4 million provided in Q1 2025.
The Board approved a regular quarterly dividend of $1.015 per share payable September 5, 2025, and a $100.0 million buyback increase running through December 31, 2026; $7.9 million remained available as of July 31, 2025.
Dentsply Sirona reported second-quarter 2025 net sales of $936 million, down 4.9% from a year earlier, and a GAAP net loss of $45 million, or $0.22 per share, driven by a $214 million net-of-tax goodwill and intangible impairment. Adjusted EPS rose to $0.52 from $0.49, and the company reaffirmed its 2025 outlook, though sales and the impairment charge weigh on the picture for shareholders.
Net sales of $936 million fell 4.9% from $984 million; down 6.7% in constant currency, with United States sales down 18.3%.
GAAP net loss attributable to Dentsply Sirona of $45 million, or $0.22 per share, versus a $4 million loss ($0.02 per share) in the second quarter of 2024.
Adjusted EPS of $0.52 compared with $0.49; 2025 outlook maintained at net sales of $3.60 billion to $3.70 billion and adjusted EPS of $1.80 to $2.00.
Dan Scavilla became CEO effective August 1, 2025; quarterly dividend of $0.16 per share is payable October 10, 2025.
N-able reported second-quarter 2025 revenue of $131.2 million, up 9.9% year over year, and total ARR of $513.7 million, up 14.5%. The company said it exceeded the high end of its second-quarter revenue and adjusted EBITDA guidance and raised its full-year 2025 ARR outlook to $525 million to $530 million, but GAAP net loss was $4.0 million, compared with net income of $9.5 million a year earlier.
Q2 2025 total revenue was $131.2 million, up 9.9% year over year (7.9% in constant currency).
GAAP net loss was $4.0 million, or $0.02 per diluted share, versus net income of $9.5 million in Q2 2024; non-GAAP net income was $20.4 million, or $0.11 per diluted share.
Full-year 2025 ARR outlook was raised to $525 million to $530 million; full-year revenue outlook is $500 million to $503 million.
Q3 2025 guidance calls for revenue of $127 million to $128 million and adjusted EBITDA of $36 million to $37 million.
Datadog reported second-quarter 2025 revenue of $827 million, up 28% from a year earlier, and gave third-quarter and full-year 2025 revenue guidance. GAAP results weakened: the company posted a $36 million operating loss and net income of $2.6 million, compared with operating income of $12.6 million and net income of $43.8 million a year earlier. Non-GAAP net income per diluted share rose to $0.46 from $0.43.
Q2 revenue was $827 million, up 28% year over year; customers with ARR of $100,000 or more rose 14% to about 3,850.
GAAP operating loss was $36 million versus operating income of $12.6 million in Q2 2024; GAAP diluted EPS was $0.01 versus $0.12.
Non-GAAP operating income was $164 million, a 20% margin, compared with 24% a year earlier.
Q3 2025 revenue guidance is $847 million to $851 million; full-year 2025 revenue guidance is $3.312 billion to $3.322 billion.
SolarEdge reported second quarter 2025 revenue of $289.4 million, up 32% from the prior quarter, and gave third quarter revenue guidance of $315 million to $355 million. The GAAP net loss widened to $124.7 million, or $2.13 per share, from $98.5 million in the prior quarter, and the company said its GAAP results include impairments, write-offs and discontinued operations. For shareholders, revenue growth and guidance point up, while the larger GAAP loss points the other way.
Q2 2025 revenue was $289.4 million, up 32% from $219.5 million in the prior quarter.
GAAP net loss was $124.7 million, or $2.13 per share, versus $98.5 million, or $1.70 per share, in the prior quarter.
Non-GAAP net loss was $47.7 million, compared with $66.1 million in the prior quarter.
Q3 2025 outlook: revenue of $315 million to $355 million and non-GAAP gross margin of 15% to 19%.
Insulet reported second-quarter 2025 revenue of $649.1 million, up 32.9% from a year earlier, and raised its full-year 2025 total revenue growth guidance to 24% to 27% in constant currency, from 19% to 22%. GAAP net income fell to $22.5 million, or $0.32 per diluted share, from $188.6 million, or $2.59, a year earlier; that prior-year figure included a tax benefit, and this year's quarter included an $84.4 million loss on extinguishment of debt. Shareholders face a mixed picture: sales and adjusted earnings rose, while GAAP profit declined sharply.
Total Omnipod revenue was $639.0 million, up 33.0%; U.S. Omnipod revenue was $453.2 million, up 28.7%, and International Omnipod revenue was $185.8 million, up 45.0%.
Full-year 2025 adjusted operating margin guidance was raised to 17.0% to 17.5% from about 16.5%.
Adjusted net income was $83.7 million, or $1.17 per diluted share, compared with $38.3 million, or $0.55, a year earlier.
The company initiated redemption of the remaining $380 million principal of its convertible notes and refinanced its Term Loan B.
Crocs reported second-quarter 2025 revenue of $1,149 million, up 3.4%, but a GAAP net loss of $492 million, or $8.82 per diluted share, driven by $737 million in noncash impairment charges tied to the HEYDUDE brand. The company guided third-quarter revenue down approximately 9% to 11%, which signals a sales decline ahead for shareholders.
Q2 2025 revenue was $1,149 million, up 3.4%; adjusted diluted EPS was $4.23, up 5.5% from $4.01.
GAAP diluted loss per share was $8.82, versus diluted earnings of $3.77 a year earlier, due to a $430 million HEYDUDE trademark impairment and a $307 million HEYDUDE goodwill impairment.
Third-quarter 2025 guidance calls for revenue down approximately 9% to 11% versus Q3 2024, and adjusted operating margin of approximately 18% to 19%.
The company repurchased about 1.3 million shares for $133 million and repaid $105 million of debt in the quarter.
Vistra reported second-quarter 2025 operating revenues of $4,250 million, up from $3,845 million a year earlier, but GAAP net income fell to $327 million from $467 million and Ongoing Operations Adjusted EBITDA fell to $1,349 million from $1,412 million, which the company attributed mainly to higher plant outage costs. Vistra reaffirmed its 2025 Ongoing Operations Adjusted EBITDA guidance of $5.5 billion to $6.1 billion and raised its 2026 Adjusted EBITDA midpoint opportunity to more than $6.8 billion, excluding a planned acquisition of seven natural gas facilities of about 2,600 MW from Lotus Infrastructure Partners.
Q2 2025 GAAP net income was $327 million, down $140 million from $467 million in Q2 2024.
Ongoing Operations Adjusted EBITDA was $1,349 million, down $63 million from $1,412 million a year earlier.
2025 Ongoing Operations Adjusted EBITDA guidance of $5.5 billion to $6.1 billion was reaffirmed.
Vistra signed a definitive agreement to acquire seven natural gas facilities of about 2,600 MW from Lotus Infrastructure Partners.
Papa John's reported second quarter 2025 results on August 7, 2025. Total revenues rose 4.2% to $529.2 million, but net income fell to $9.7 million from $12.5 million and diluted earnings per share fell to $0.28 from $0.37. The company reiterated most of its 2025 outlook and raised its International comparable sales range to up 2% to 4%.
Total revenues were $529.2 million, up $21.3 million or 4.2%, mainly due to a $20.3 million increase in Commissary revenues.
Net income was $9.7 million versus $12.5 million, and adjusted EBITDA was $52.6 million versus $58.9 million a year earlier.
Adjusted diluted EPS was $0.41 versus $0.61 in the prior year second quarter.
International comparable sales guidance was raised to up 2% to 4% from flat to up 2%; adjusted EBITDA guidance of $200 million to $220 million was reiterated.
Peloton reported fiscal fourth-quarter and full-year FY2025 results on August 7, 2025. Q4 total revenue fell 6% year-over-year to $606.9 million, while GAAP net income was $21.6 million, compared with a net loss of $30.5 million a year earlier, and Adjusted EBITDA rose 99% to $140.0 million. The company guided FY26 total revenue to $2.4 billion to $2.5 billion, a 2% decline at the midpoint, and announced a restructuring plan targeting at least $100 million of run-rate savings by the end of FY26.
Q4 FY25 total revenue was $606.9 million, down 6% year-over-year, with Total Gross Margin of 54.1%.
Q4 GAAP net income was $21.6 million versus a net loss of $30.5 million in Q4 FY24; Adjusted EBITDA was $140.0 million.
FY26 guidance: total revenue of $2.4 billion to $2.5 billion and Adjusted EBITDA of $400 million to $450 million.
Q1 FY26 total revenue is guided to $525.0 million to $545.0 million, down 9% at the midpoint; restructuring targets at least $100 million of run-rate savings by the end of FY26.
Advanced Drainage Systems reported fiscal first-quarter 2026 net sales up 1.8% to $829.9 million, but net income fell 11.2% to $144.1 million and diluted earnings per share fell 10.7% to $1.84. Management cited wet weather that delayed project installations and elevated interest rates; the company confirmed its fiscal 2026 targets and declared a quarterly dividend of $0.18 per share, up 13% from the prior year.
Net sales rose $14.5 million, or 1.8%, to $829.9 million, driven by the Orenco acquisition and construction end markets
Diluted EPS fell to $1.84 from $2.06; adjusted EPS was $1.95, down 5.3%
Fiscal 2026 targets confirmed: net sales of $2.825 billion to $2.975 billion and Adjusted EBITDA of $850 million to $910 million
Quarterly dividend of $0.18 per share payable September 15, 2025, to holders of record on August 29, 2025
Hyatt reported second-quarter 2025 net loss attributable to the company of $3 million, or $(0.03) per diluted share, compared with net income of $359 million a year earlier, which included gains on sales of real estate. Revenue rose to $1,808 million from $1,703 million and gross fees rose 9.5%, while adjusted EBITDA fell 1.1% to $303 million. The company also set full-year 2025 net income guidance of $135 million to $165 million, down sharply from $1,296 million in 2024, and disclosed the pending $2.0 billion sale of Playa's real estate.
Q2 2025 net loss attributable to Hyatt of $3 million, or $(0.03) per diluted share, versus net income of $359 million, or $3.46 per diluted share, in Q2 2024
Q2 revenue of $1,808 million, up from $1,703 million; gross fees of $301 million, up 9.5%; adjusted EBITDA of $303 million, down 1.1%
Transaction and integration costs of $82 million in Q2 2025 versus $10 million a year earlier
Full-year 2025 net income outlook of $135 million to $165 million versus $1,296 million in 2024; Playa real estate sale to Tortuga Resorts for $2.0 billion expected to close before end of 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.